1031284-87-3

Upstream product

• 78471-43-9 methyl 4-bromo-2-(bromomethyl)benzoate 
• 350-46-9 4-Fluoronitrobenzene 
• 132784-74-8 2-amino-6-trimethylacetamidopyridine 
• 86847-84-9 2,2-Dimethyl-N-(6-chloro-2-pyridinyl)propanamide 
• 443914-85-0 1-isopropyl-4-(4-nitrophenyl)piperazine 
• 800402-05-5 N-(6-chloro-3-iodopyridin-2-yl)-tert-butylamide 
• 800402-06-6 6-chloro-3-iodo-pyridin-2-ylamine 
• 552330-86-6 5-bromoisoindolin-1-one 
• 443914-86-1 4-(4-(2-propyl)-piperazin-1-yl)aniline 
• 1031289-77-6 5-chloro-8-iodo-imidazo[1,2-a]pyridine 
• 141-86-6 2.6-diaminopyridine 
• 4318-42-7 1-(1-methylethyl)piperazine 
• 376584-62-2 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoindolin-1-one 
• 1031290-25-1 (5-chloroimidazo[1,2-a]pyridin-8-yl)-[4-(4-isopropylpiperazin-1-yl)phenyl]amine 

Relevant academic research and scientific papers

IMIDAZOLOPYRIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES

Novel imidazolopyridine compounds are disclosed that have a formula represented by Formula (I). The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, ECM degradation, joint degradation and/or inflammation, and others.